Big Pharma

5 trends in biotech dealmaking to watch in 2021
5 trends in biotech dealmaking to watch in 2021
BioPharma Dive
biotech
Neuroscience
SPAC
Big Pharma
private equity
Flag link:
Antitrust Panel Sets Sights on Big Pharma for Next Target
Antitrust Panel Sets Sights on Big Pharma for Next Target
BioSpace
Big Pharma
antitrust
FTC
M&A
Flag link:
Will Big Pharma Acquire Novavax?
Will Big Pharma Acquire Novavax?
Motley Fool
Novavax
vaccines
M&A
Big Pharma
pandemic
COVID-19
Flag link:
Esmo 2020 preview – late-breaking immunotherapy
Esmo 2020 preview – late-breaking immunotherapy
EP Vantage
ESMO
immunotherapy
Big Pharma
Merck
Bristol-Meyers Squibb
cancer
Immunomedics
Roche
Flag link:
Big pharma spinouts grow up
Big pharma spinouts grow up
EP Vantage
Big Pharma
spinoffs
Merck KGaA
Pfizer
GSK
Novartis
Roche
Sanofi
JNJ
AstraZeneca
Flag link:
Kamala Harris' stance on Big Pharma: 5 things to know
Kamala Harris' stance on Big Pharma: 5 things to know
Beckers Hospital Review
Kamala Harris
2020 Presidential election
Big Pharma
Joe Biden
Flag link:
Trump and Big Pharma tussle over drug price proposal with 3 months until election
Trump and Big Pharma tussle over drug price proposal with 3 months until election
Fierce Pharma
Donald Trump
Big Pharma
drug pricing
Flag link:
Pharma deal values plummet 56% as COVID-19 disrupts resources: report
Pharma deal values plummet 56% as COVID-19 disrupts resources: report
Fierce Pharma
Big Pharma
M&A
pandemic
COVID-19
Flag link:
It’s official: “pipeline in a product” is a thing
It’s official: “pipeline in a product” is a thing
EP Vantage
drug development
Big Pharma
pipeline in a product
Flag link:
How COVID-19 has affected product sales at the top 15 pharma companies
How COVID-19 has affected product sales at the top 15 pharma companies
Beckers Hospital Review
COVID-19
pandemic
drug sales
Big Pharma
Flag link:
Big pharma, battling COVID-19, looks to 'buy time' on another health crisis: superbugs
Big pharma, battling COVID-19, looks to 'buy time' on another health crisis: superbugs
BioPharma Dive
antibiotics
superbugs
Big Pharma
Eli Lilly
Antimicrobial Resistance Action Fund
Flag link:
Coalition of drugmakers to unveil $1B venture to pursue antibiotics
Coalition of drugmakers to unveil $1B venture to pursue antibiotics
Beckers Hospital Review
Big Pharma
drug development
antibiotics
innovation
Eli Lilly
Pfizer
Merck
Boehringer Ingelheim
Bayer
CARB-X
Flag link:
Big pharma sports smallest late-stage pipeline for a decade
Big pharma sports smallest late-stage pipeline for a decade
EP Vantage
Big Pharma
drug development
pandemic
COVID-19
Flag link:
Big Pharma remains bullish in the face of Covid-19
Big Pharma remains bullish in the face of Covid-19
EP Vantage
COVID-19
pandemic
Big Pharma
Flag link:
While Big Pharma Tanked, Gilead Sciences and Regeneron Soared
While Big Pharma Tanked, Gilead Sciences and Regeneron Soared
Motley Fool
Big Pharma
Gilead Sciences
Regeneron
Flag link:
Big Pharma wants billions more for COVID-19 funding pot
Big Pharma wants billions more for COVID-19 funding pot
Fierce Pharma
Big Pharma
coronaviruses
COVID-19
vaccines
drug development
government funding
Flag link:
Big pharma backed away from brain drugs. Is a return in sight?
Big pharma backed away from brain drugs. Is a return in sight?
BioPharma Dive
Big Pharma
Neuroscience
AstraZeneca
Bristol-Myers Squibb
GSK
Pfizer
Amgen
Flag link:
AZ, Merck and Novartis top Big Pharma's Q3 growth charts. Teva and Pfizer? Not so much
AZ, Merck and Novartis top Big Pharma's Q3 growth charts. Teva and Pfizer? Not so much
Fierce Pharma
earnings
Big Pharma
AstraZeneca
Merck
Celgene
Novartis
Novo Nordisk
Pfizer
Flag link:
Big Pharma game heading for console release next month
Big Pharma game heading for console release next month
Pharmaforum
Big Pharma
simulation
Flag link:
How big pharma and startups can learn from each other
How big pharma and startups can learn from each other
Pharmaforum
startups
Big Pharma
digital pharma
Flag link:

Pages